Production of biodiesel through esterification catalysed by Ionic liquids

Biodiesel is an alternative diesel fuel that is produced from vegetable oils and animal fats. Currently, most biodiesel is made from oils, methanol, and an alkaline catalyst. Conventional catalysts is commonly used for catalyzing esterification of fatty acid to produce biodiesel. However, a better and greener method was found. An ionic liquid (IL) is a molten salt consisting of a cation and an anion, with low melting temperature. It offers a better solution than sulfuric acid, because it can be recycled and reused in subsequent runs after recovery steps. In this study, a Brønsted acidic IL, 1-butyl-3-methylimidazolium hydrogen sulfate ([BMIM][HSO4]) was used as a catalyst in the esterification of oleic acid with methanol into biodiesel. The effect of different operation parameters such as methanol to oil molar ratio, amount of catalyst, reaction temperature, and reaction time were tested. The optimum conditions for esterification of oleic acid were identified as oleic acid/methanol molar ratio of 1/10, amount of catalyst 10 wt%, reaction time of 4 h, and reaction temperature of 90oC. FAME content of produced biodiesel was analyzed and confirmed using GC chromatography.

Wild Roman chamomile extracts and phenolic compounds: enzymatic assays and molecular modelling studies with VEGFR-2 tyrosine kinase

Angiogenesis is a process by which new blood vessels are formed from the pre-existing vasculature, and it is a key process that leads to tumour development. Some studies have recognized phenolic compounds as chemopreventive agents; flavonoids, in particular, seem to suppress the growth of tumor cells modifying the cell cycle. Herein, the antiangiogenic activity of Roman chamomile (Chamaemelum nobile L.) extracts (methanolic extract and infusion) and the main phenolic compounds present (apigenin, apigenin-7-O-glucoside, caffeic acid, chlorogenic acid, luteolin, and luteolin-7-O-glucoside) was evaluated through enzymatic assays using the tyrosine kinase intracellular domain of the Vascular Endothelium Growth Factor Receptor-2 (VEGFR-2), which is a transmembrane receptor expressed fundamentally in endothelial cells involved in angiogenesis, and molecular modelling studies. The methanolic extract showed a lower IC50 value (concentration that provided 50% of VEGFR-2 inhibition) than the infusion, 269 and 301 μg mL(-1), respectively. Regarding phenolic compounds, luteolin and apigenin showed the highest capacity to inhibit the phosphorylation of VEGFR-2, leading us to believe that these compounds are involved in the activity revealed by the methanolic extract.